North America Cardiac Biomarkers Testing Market By Type (Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others), By Location of Testing (Point of Care Testing and Laboratory Testing)

Analysis of Market Size & Trends

The North America Cardiac Biomarkers Testing Market would witness market growth of 10.7% CAGR during the forecast period (2019-2025). Cardiac biomarkers are used when cardiac myocytes are damaged partially or completely, and measuring these biomarkers in serum or plasma is useful during the diagnosis of myocardial infarction. Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome, and cardiac troponin (especially troponin I) is particularly useful in the diagnosis of myocardial infection due to its superior specificity compared to other cardiac biomarkers. Individuals who note symptoms of myocardial infarction and elevated troponin I or troponin T, are now classified as non-ST-segment elevation MI (NSTEMI). North America is dominating the global market, which can be attributed to the rising demand for cardiac testing, higher CVD prevalence rate, and the growing awareness towards cardiac diagnostics solutions.

Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

Click Here For Free Insights

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.

Scope of the Cardiac Biomarkers Testing Market Analysis

Market Segmentation:

By Type

• Creatine Kinase (CK-MB)
• Troponins
• Myoglobin
• Natriuretic Peptides (BNP and NT-proBNP)
• Ischemia Modified Albumin
• Others

By Application

• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Atherosclerosis
• Others

By Location of Testing

• Point of Care Testing
• Laboratory Testing

By Country

• US
• Canada
• Mexico
• Rest of North America

Companies Profiled

• Trivitron Healthcare Pvt. Ltd.
• Abbott Laboratories
• Siemens AG
• Becton, Dickinson AND Company
• Bio-Rad Laboratories, Inc.
• Randox Laboratories Limited
• Danaher Corporation
• Thermo Fisher Scientific, Inc.
• Johnson and Johnson
• Quidel Corporation